Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
US-11149077-B2 · Oct 19, 2021 · US
This page is not indexed by search engines while we improve data quality.
Gage Patrick patents
Gage Patrick is listed as an inventor on 5 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Gage Patrick |
| Total patents | 5 |
| First publication | Sep 10, 2015 |
| Latest publication | Oct 19, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US-2019202894-A1 · Jul 4, 2019 · US
Methods of treating cancer by administering IGF-IR binding molecules
US-10221232-B2 · Mar 5, 2019 · US
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US-2017190761-A1 · Jul 6, 2017 · US
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US-2015252097-A1 · Sep 10, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C40B40/10 | 5 |
| C07K2317/92 | 5 |
| A61K47/60 | 5 |
| A61P43/00 | 5 |
| C40B30/04 | 5 |